ILMN Live signals | Maximize Profits with Getagraph.com

BUY 15 min ago

@ $118.97

Issued: 26 Apr 2024 @ 09:30

Return: 2.69%

Previous signal: Apr 25 - 11:28

Previous signal: Sell

Return: 0.48 %

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 09:44):

Stats
Today's Volume	28 245.00
Average Volume	1.65M
Market Cap	19.41B
EPS	$0 ( 2024-02-08 )
Next earnings date	( $0.0400 ) 2024-05-16
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-16.64
ATR14	$5.06 (4.14%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-15	Dhingra Ankur	Buy	0
2024-04-15	Wedel Christensen Jakob	Sell	0	Common Stock
2024-04-15	Wedel Christensen Jakob	Sell	1 393	Performance Shares
2024-04-05	Rollins Carissa	Sell	122	Common Stock
2024-03-28	Ullem Scott B.	Buy	163	Common Stock

INSIDER POWER
81.87
Last 98 transactions
Buy: 298 708 \| Sell: 33 999

Volume Correlation

Long: 0.16 (neutral)

Short: 0.88 (strong)

Signal:(59) Same movement expected

Illumina Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations
BNIXU	-0.835

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Illumina Inc Correlation - Currency/Commodity

0.36
( neutral )

0.24
( neutral )

0.00
( neutral )

0.52
( weak )

0.60
( weak )

-0.31
( neutral )

Illumina Inc Financials

Annual	2023
Revenue:	$4.50B
Gross Profit:	$2.75B (61.06 %)
EPS:	$-7.35

FY	2023
Revenue:	$4.50B
Gross Profit:	$2.75B (61.06 %)
EPS:	$-7.35

FY	2022
Revenue:	$4.58B
Gross Profit:	$2.97B (64.83 %)
EPS:	$-28.05

FY	2021
Revenue:	$4.53B
Gross Profit:	$3.15B (69.69 %)
EPS:	$5.07

Financial Reports:

No articles found.

Illumina Inc

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.